Kristen Fortney is the CEO and co-founder of BioAge, a clinical-stage biotechnology company. BioAge focuses on developing a pipeline of treatments designed to extend healthy lifespan.

The company achieves this by targeting the molecular causes of aging. BioAge utilizes a discovery platform that combines quantitative analysis of proprietary longitudinal human samples with detailed health records. This platform helps map out key molecular pathways that influence healthy human aging.